Announcements

Latest announcements

Sativa invests C$ 0.2 million in Canadian-based Rapid Dose Therapeutics Inc

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, has subscribed to, through a private placement which may or may not precede an IPO, 400,000 shares at C$ 0.50 per share, at a cost of C$ 0.2 million cash, in Toronto-based Pharma-Tech company, Rapid Dose Therapeutics Inc. (“RDT”).

Sativa Investments commits to C$ 0.2 million investment in Canadian-based Veritas Pharma

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, has subscribed for 500,000 new shares at C$ 0.40 per share, at a cost of C$ 0.2 million cash, in Canadian-based emerging global pharmaceutical company Veritas Pharma Inc (or “Veritas Pharma”), which is tri-listed on the Canadian Securities Exchange, America’s OTC exchange and the Frankfurt Stock Exchange.

Veritas Pharma

Veritas Pharma Inc. is an emerging global pharmaceutical company based out of Vancouver, Canada that’s investing in the discovery, product development and commercialization of effective, patented cannabis therapies that target disease conditions in the areas of chronic pain, senior long-term care and palliative care.

Orderly Market Agreement – Director’s Dealing

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that, on 16 April 2018, Noel Lyons, a non-executive director of the Company, sold 750,000 ordinary shares of £0.0025 each in the Company at a price of £0.03 per share pursuant to an orderly market agreement with Peterhouse Corporate Finance Limited to satisfy market demand.

Sativa Investments PLC MOU with George Botanicals

Sativa Investments PLC [NEX:SATI], the UK’s first medicinal cannabis investment vehicle, has signed a Memorandum of Understanding (“MOU”) with George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor of wellness CBD products, to purchase a 51 per cent shareholding from its owner, Carbon Managers Limited (“Carbon Managers”) for an expected consideration of circa £200,000. George Botanicals has been providing its customers with high quality natural CBD products since September 2017, including vape pens, balms, E-Liquids, drops and edible gels that are shipped throughout the UK and are 100 per cent laboratory tested.